John Varian - 01 Jan 2023 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
Director
Signature
/s/ Neil S. Belloff, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 06:56:38 UTC
Previous filing
01 Feb 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Non-Employee Stock Option Award $0 +4,712 $0.000000 4,712 01 Jan 2023 Common Stock 4,712 $0.7667 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in four equal quarterly installments over 12 months with the first quarterly installment vesting on April 1, 2023.